Work

Evidence that CD32a does not mark the HIV-1 latent reservoir

Year: 2018

Type: article

Source: Nature

DOI: 10.1038/s41586-018-0495-2

Authors: Christa E. Osuna, So-Yon Lim, Jessica L. Kublin, Richard Apps, Elsa Chen, Talia M. Mota, Szu-Han Huang, Yanqin Ren, Nathaniel D. Bachtel, Athe M. Tsibris, Margaret E. Ackerman, R. Brad Jones, Douglas F. Nixon, James B. Whitney

Institutions: Beth Israel Deaconess Medical Center, Harvard University, National Institute of Allergy and Infectious Diseases, Weill Cornell Medicine, Brigham and Women's Hospital, Dartmouth College, Ragon Institute of MGH, MIT and Harvard

Language: English

Topic: HIV Research and Treatment

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institute of Allergy and Infectious Diseases

Awards: TLR Therapy to Eradicate the SIV Reservoir, Viral dynamics of rebound and control following early treatment of HIV/SIV, BELIEVE: Bench to Bed Enhanced Lymphocyte Infusions to Engineer Viral Eradication, Mechanisms of SIV persistence, TLR Immunotherapy to Eradicate Anatomic SIV Reservoirs, Multidisciplinary HIV Training Program

OpenAlex ID: W2892297817

FWCI: 5.243

Cites: 15

Cited by: 53

Related to: 10